News

VolitionRx Showcases Groundbreaking Research in Lung Cancer

VolitionRx Showcases Groundbreaking Research in Lung Cancer

VolitionRx's Innovative Contributions to Lung Cancer Research

VolitionRx Limited (NYSE AMERICAN: VNRX) stands at the forefront of groundbreaking studies that potentially transform the landscape of lung cancer diagnosis. At the European Society for Medical Oncology (ESMO)'s European Lung Cancer Congress 2025, the company will present two significant posters that highlight their pioneering developments in cancer biomarkers and immunoassays. These advancements promise to improve prognostic evaluations and support treatment decisions in patients diagnosed with Non-Small Cell Lung Cancer (NSCLC).

Key Findings on Nu.Q® H3K27Me3 Biomarker

The first poster presentation centers on Volition's Nu.Q® H3K27Me3 biomarker. This particular biomarker, when used in conjunction with circulating tumor DNA (ctDNA), shows promise in enhancing overall survival projections. The results offer critical insights into how combining these technologies might lead to more informed treatment options for NSCLC patients.

Improving Patient Outcomes

By integrating the Nu.Q® H3K27Me3 biomarker into standard diagnostics, physicians may gain a better understanding of patient prognoses. This enhanced insight is essential for developing tailored treatment approaches that align closely with individual patient needs, potentially leading to improved outcomes.

Early Cancer Detection with Nu.Q® H3.1 Immunoassay

The second poster details the Nu.Q® H3.1 immunoassay, a cost-effective tool for early cancer detection. This innovative test can identify individuals at high risk for developing cancer, allowing for timely interventions. It represents a significant step forward in the quest for early cancer detection, which is often critical for successful treatment and management.

Cost-Efficient and Accessible Testing

One of the standout features of the Nu.Q® H3.1 test is its affordability, making it accessible to a wider population. This inclusivity helps ensure that more patients can benefit from early detection, thereby improving the overall quality of cancer care. With the ability to identify high-risk patients effectively, healthcare providers can implement preventive strategies earlier in the disease course.

Details of the Poster Sessions at ELCC 2025

Clinicians and researchers attending ELCC 2025, which will be held from March 26-29, 2025, in Paris, will have the opportunity to visit Volition's poster sessions. The first poster, designated as #282P, focuses on the early detection strategies for lung cancer. It will feature Jake Micallef, PhD, MBA, serving as the presenter for this vital study.

The second poster, #395P, will delve into the potential of the H3K27Me3 biomarker as a prognostic tool. This session will be led by Marie Piecyk, PhD, from the Center for Innovation in Cancerology of Lyon.

Volition's Commitment to Advancing Epigenetics

VolitionRx is dedicated to transforming the field of medical diagnostics by leveraging the power of epigenetics. The company aims to enhance early detection strategies for various diseases, including cancers and conditions associated with NETosis, such as sepsis. By providing simple and cost-effective blood tests, VolitionRx aims to improve the diagnosis and monitoring of serious health issues.

The company's research facilities are strategically located across various regions, including Belgium and the United States, supporting their mission of improving patient care globally.

About VolitionRx Limited

VolitionRx Limited is committed to advancing epigenetic science. With an emphasis on earlier disease detection and treatment monitoring, VolitionRx seeks to enhance outcomes for individuals suffering from life-threatening conditions. Their innovative approach includes the development of easy-to-use blood tests that can make a significant difference in both lives and healthcare.

Frequently Asked Questions

What is VolitionRx known for?

VolitionRx is recognized for its innovative biomarkers and immunoassay technologies aimed at improving cancer diagnosis and treatment.

What are the benefits of the Nu.Q® H3.1 immunoassay?

This immunoassay offers a cost-effective method for early cancer detection, allowing for timely interventions and better outcomes.

Where will the poster sessions take place?

The poster sessions will take place at the ESMO's European Lung Cancer Congress 2025 in Paris, showcasing cutting-edge research by Volition.

Who are the presenters at the poster sessions?

Jake Micallef and Marie Piecyk are the key presenters for Volition's posters, sharing critical insights from their research.

What is the significance of the Nu.Q® H3K27Me3 biomarker?

This biomarker enhances prognostic evaluations for NSCLC, potentially guiding treatment decisions for better patient management.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 7

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 8

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 8

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 6

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading

Top 5 Most Recently Viewed Articles

The Rise of Digital Travel Credentials: A New Era in Travel Security

Updated Category News Views 231

Understanding Digital Travel Credentials and Their Impact Digital Travel Credentials (DTCs) are emerging as a crucial aspect of the modern travel landscape. These credentials represent the evolution of digital identity, driven by advancements in technology and a growing need for enhanced security and efficiency in travel systems. The push for DTCs is spearheaded by market...

Continue Reading
White River Bancshares Achieves Significant Earnings Growth

Updated Category News Views 87

Overview of Financial Performance White River Bancshares Company (OTCQX: WRIV), the parent company of Signature Bank of Arkansas, has recently announced remarkable financial results for the fourth quarter of the fiscal year. The company achieved a net income of $1.83 million, which translates to a robust $0.75 per diluted share. This represents a significant increase from...

Continue Reading
Troy Glover Joins Oceanview Life and Annuity Company as EVP

Updated Category News Views 412

Oceanview Life and Annuity Company Welcomes Troy Glover Oceanview Life and Annuity Company, known for its innovative approach to retirement solutions, has made a significant enhancement to its leadership team with the announcement of Troy E. Glover as the new Executive Vice President of Operations. Glover's appointment marks a strategic move for Oceanview, as he will play...

Continue Reading
XTI Aerospace Plans Strategic Town Hall on Drone Innovations

Updated Category News Views 115

XTI Aerospace Plans Strategic Town Hall on Drone Innovations Company to Outline 2026 Growth Priorities and Unmanned Aircraft Systems Expansion XTI Aerospace, Inc. (NASDAQ: XTIA) is leading the way in aerospace technology and is set to transform its operations with exciting developments. In a significant move, XTI has acquired Drone Nerds, a company dedicated to unmanned...

Continue Reading
Rising Trend in Foreign Visitors Attending Japanese Performances

Updated Category News Views 267

Growing Interest in Japanese Cultural Performances Suntory Publicity Service Ltd. (hereinafter "SPS"), recognized for its consulting services in cultural and corporate facilities, has conducted a survey revealing interesting insights into the engagement of foreign visitors with Japanese theaters and concert halls. This survey indicates a significant trend: foreign...

Continue Reading